Oklahoma Center for Orthopaedic & Multi-Specialty Surgery, LLC
Oklahoma Center for Orthopaedic & Multi-Specialty Surgery, LLC was paid $2.83M by Medicaid between Jan 2018 and Oct 2024, across 22 billing codes. Its largest line is D9999, Unspecified adjunctive procedure, by report — 82% of everything it billed.
OKLAHOMA CITY, OK 73139
Next to other General Acute Care Hospital providers in Oklahoma
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,422 | $599K | |
| 2019 | 2,593 | $700K | |
| 2020 | 2,156 | $429K | |
| 2021 | 2,405 | $477K | |
| 2022 | 3,677 | $362K | |
| 2023 | 3,904 | $209K | |
| 2024incomplete | 743 | $52K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| D9999 | Unspecified adjunctive procedure, by report | 82% | 2,668 | 2,667 | $2.31M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 8.8% | 691 | 691 | $248K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 5.0% | 198 | 198 | $141K |
| 64493 | 1.7% | 152 | 126 | $49K | |
| 88342 | <1% | 322 | 322 | $28K | |
| 43248 | <1% | 62 | 62 | $28K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 104 | 103 | $13K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,064 | 4,035 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,963 | 3,951 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 27 | 27 | $1K |
| 72100 | <1% | 13 | 13 | $309.23 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 14 | 14 | $237.04 |
10 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12 | $63.17 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 14 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 2,072 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 2,763 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 195 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 153 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 12 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 76 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 313 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.